Clinical Trial Update: Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing ocular signs and symptoms when glaucoma patients switch from latanoprost to preservative-free tafluprost eye drops.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• Tafluprost (preservative-free) (tafluprost)

Snippet

Sponsor: Santen Oy | Conditions: Ocular Hypertension, Open-Angle Glaucoma | Phase 3 | Status: COMPLETED